Alzheimer's Drugs Hope As NICE Appeal Denied

Main Category: Alzheimer's / Dementia
Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 30 Oct 2008 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:5 stars

5 (1 votes)


New hope has been offered to thousands of people in the early stages of Alzheimer's today, 29 October, following a landmark decision in the House of Lords.

The Lord's denied the National Institute for Health and Clinical Excellence (NICE) the right to appeal a high court decision which, in May 2008, ordered NICE to release a copy of the model it used to restrict Alzheimer's drugs on the NHS.

People in the early stages of Alzheimer's are currently denied the only drug treatments for the disease because NICE ruled they are too expensive, at a cost of just £2.50 a day.

Neil Hunt, Chief Executive of Alzheimer's Society says,

Today is a small victory in the battle to see justice for thousands of people with Alzheimer's disease and their families. Having access to NICE's model will allow us to scrutinise NICE's calculation and to try and make sense of this unfathomable decision.

We strongly believe that NICE's decision to deny people in the early stages of Alzheimer's disease access to drugs is fundamentally flawed. For the price of a cup of coffee, drug treatments can give people hope, dignity and time when it is the most precious.

If NICE has got it wrong, the decision must be scrapped and people should be given back their right to have treatment.

Notes

Since May 2006 three Alzheimer's drugs have been denied to people in the early stages of the disease on the NHS.

On 1 May 2008 the Court of Appeal found in favour of Eisai/Pfizer ruling NICE should have allowed public access to the health economic model that it used to make its decision.

On 17 June 2008 NICE sought permission from the House of Lords to appeal the Court of Appeal decision.

In Northern Ireland NICE guidance will have to be endorsed by the Minister for Health, Michael McGimpsey, before it can be implemented.

1 in 3 people over the age of 65 will die with dementia.

700,000 people in the UK have a form of dementia, more than half have Alzheimer's disease. In less than 20 years nearly a million people will be living with dementia. This will soar to 1.7 million people by 2051.

Dementia is not a natural part of ageing; it is caused by diseases of the brain and robs people of their lives.

Alzheimer's Society champions the rights of people living with dementia and those who care for them. Alzheimer's Society works in England, Wales and Northern Ireland.

Alzheimer's Society needs to raise money to care for people today and to find a cure for tomorrow. You can donate now by calling 0845 306 0898 or visiting http://www.alzheimers.org.uk

Alzheimer's Society provides a National Dementia Helpline, the number is 0845 300 0336

Alzheimer's Society

Article adapted by Medical News Today from original press release.
Visit our alzheimer's / dementia section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Alzheimer's Society. "Alzheimer's Drugs Hope As NICE Appeal Denied." Medical News Today. MediLexicon, Intl., 30 Oct. 2008. Web.
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/127436.php>

APA
Alzheimer's Society. (2008, October 30). "Alzheimer's Drugs Hope As NICE Appeal Denied." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/127436.php.

Please note: If no author information is provided, the source is cited instead.


Alzheimer's / Dementia

What is Dementia?

The word dementia comes from the Latin de meaning "apart" and mens from the genitive mentis meaning "mind". Dementia is the progressive deterioration in cognitive function - the ability to process thought (intelligence). Read more...

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. Read more...

Most Popular Articles



Follow Our Alzheimer's News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Alzheimer's / Dementia Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »